Sartorius, DE0007165631

Sartorius stock falls 1 percent as analysts see room to 284 euros

Published on 09/23/2026 at 14:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sartorius stock traded at EUR 250.40 on September 23, 2026, down 1 percent in Xetra trading. Q2 EPS reached EUR 0.95 versus EUR 0.47.

Fotorealistische Bioreaktor-Anlage in Reinraumhalle mit Edelstahltanks und Technikern
Sartorius AG (Vz.) DE0006292006 zeigt fotorealistisch eine sterile Bioreaktor-Anlage mit Technikern in weißer Reinraum-Schutzkleidung, Illustration mit AI erstellt.

Sartorius AG (ISIN DE0007165631) traded at EUR 250.40 on Xetra at 9:06 a.m. on September 23, 2026, down 1 percent, while the 52-week range stood at EUR 189.90 to EUR 267.70. The move followed a 1.73 percent gain to EUR 253.00 on September 22, 2026, keeping the stock 6.46 percent below its reported yearly high.

Deutsche Bank keeps 284 euro target

According to finanzen.ch on September 22, 2026, Deutsche Bank Research left its Buy rating unchanged and set a price target of EUR 284. The target is EUR 33.60 above the Xetra reference price of EUR 250.40, equivalent to 13.42 percent.

The bank expects the third quarter to resemble the first half of 2026, with performance in the middle of the full-year target ranges, according to the same dated analyst report published by finanzen.ch. That assessment makes the upcoming quarterly figures the clearest test for whether the current price can close the gap to the analyst target.

Second quarter EPS doubled year over year

Sartorius reported second-quarter 2026 revenue of EUR 911.80 million, compared with EUR 884.30 million in the prior-year quarter, according to the September 23, 2026 market report. Earnings per share reached EUR 0.95, up from EUR 0.47 a year earlier, a year-over-year increase of EUR 0.48.

The next Q3 2026 figures are expected on October 22, 2026, as stated in the dated market report. The comparison between the EUR 911.80 million quarterly revenue and the EUR 884.30 million prior-year figure shows a EUR 27.50 million increase, while the EPS comparison points to a larger earnings improvement than the top-line change.

Stock remains below January high

The Xetra price of EUR 250.40 on September 23, 2026, was EUR 17.30 below the 52-week high of EUR 267.70 recorded on January 8, 2026. It was EUR 60.50 above the 52-week low of EUR 189.90 recorded on October 1, 2025.

Sartorius stock therefore entered the next reporting checkpoint below its yearly peak but above its 52-week low. The figures from the second quarter and the EUR 284 analyst target provide two separate reference points for the October 22, 2026 results date.

EUR 250.40 marks the latest level

Sartorius stock stood at EUR 250.40 on Xetra at 9:06 a.m. on September 23, 2026, after a 1 percent decline. The same report recorded 1,618 shares traded by that time.

Sartorius stock facts

  • Company: Sartorius AG
  • ISIN: DE0007165631
  • Ticker: SRT3
  • Trading venue: Xetra
  • Price as of September 23, 2026, 9:06 a.m.: EUR 250.40
  • 52-week range: EUR 189.90 to EUR 267.70
  • Sector / Industry: Health Care / Life Sciences Tools and Services
  • Index membership: TecDAX
  • Next earnings date: October 22, 2026

More news and analyses on Sartorius stock

Disclaimer...

en | DE0007165631 | SARTORIUS | boerse | 70166835 | bgmi